Skip to main content
Equibles
CARL logo

CARL · Carlsmed, Inc. · Earnings Call Transcripts & Audio

Track CARL — free

Use CARL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CARL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$15.34 +0.61 (+4.14%) At close · Sep 14
Russell 2000 member Rebalance outlook locked
Market Cap
$420.46M
Shares
27.30M

Carlsmed, Inc. Earnings Call Transcripts

Quarterly earnings calls for Carlsmed, Inc. (CARL), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲98.7% $12.08M −$6.77M '25 Q2 25-08-28 ▲98.4% $13.07M −$8.53M '25 Q3 25-11-06 · $15.16M −$8.61M '25 Q4 26-02-25 ▲58.2% $16.12M −$8.70M '26 Q1 26-05-05 LATEST ▲56.7% $18.94M −$10.51M '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
Carlsmed, Inc. (CARL) Q2 2026 Earnings Call Transcript
Confident tone Prevo Cervical and Quora Launch Revenue Growth and Guidance Raise Lumbar Franchise Expansion (Bilateral)
Revenue
$18.94M
▲ 56.7% YoY
Diluted EPS
$-0.39
Gross margin
76.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-16
Carlsmed, Inc. (CARL) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript
Confident tone Aprivo platform and product portfolio Revenue growth and Q1 results Cervical expansion
Revenue
$16.12M
▲ 58.2% YoY
Diluted EPS
$-0.32
Gross margin
77.1%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript
Confident tone Patient-Centric Innovation and Product Launches 2026 Guidance and Cautious Outlook Cervical Market Expansion
Revenue
$15.16M*
Gross margin
76.5%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Carlsmed, Inc. (CARL) Q3 2025 Earnings Call
Revenue
$13.07M
▲ 98.4% YoY
Diluted EPS
$-0.40
Gross margin
75.9%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-28
Carlsmed, Inc. (CARL) Q2 2025 Earnings Call
Revenue
$12.08M
▲ 98.7% YoY
Diluted EPS
$-1.47
Gross margin
73.4%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–6 of 6 earnings calls
Key facts CIK 1794546 CUSIP 14280C105 13F (30d) 3 filings 3 filers Visit website Investor relations